Home›Stock Screener›Trimurthi›Intrinsic Value

Trimurthi Intrinsic Value

Trimurthi intrinsic value. Trimurthi (NOVELIX) median intrinsic value is ₹20.10 from 3 valuation models (range ₹13–₹34), vs current price ₹67.00 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read Trimurthi dividend payments for the complete payout history and dividend yield track record.

Market Price (CMP)
₹67.00
Primary Intrinsic Value
₹13.40
Market Cap
₹53.6 Cr
-70.0% Downside
Median Value
₹20.10
Value Range
₹13 - ₹34
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%

NOVELIX Valuation Methods Summary — DCF, Graham Number & P/E

Trimurthi intrinsic value across 3 models vs current price ₹67.00 — upside/downside and value range per method. Compare with NOVELIX stock valuation models to assess whether the stock is under or overvalued.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹13.40 ₹12.06 - ₹14.74 -80.0% Book Value/Share: ₹10.00, P/B: 1.0x
Revenue Multiple Method revenue ₹20.10 ₹18.09 - ₹22.11 -70.0% Revenue/Share: ₹5.00, P/S: 0.8x
Simple DCF (5Y) dcf ₹33.96 ₹27.17 - ₹40.75 -49.3% CF Growth: 15.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

NOVELIX Intrinsic Value vs Market Price — All Valuation Models

Trimurthi fair value range ₹13–₹34 vs current market price ₹67.00 across 3 valuation models. For current market price and key ratios, visit Trimurthi stock price NSE.

NOVELIX Intrinsic Value Analysis — Undervalued or Overvalued?

Trimurthi median intrinsic value ₹20.10, current price ₹67.00 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.

What is the intrinsic value of NOVELIX?

Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Trimurthi (NOVELIX) is ₹20.10 (median value). With the current market price of ₹67.00, this represents a -70.0% variance from our estimated fair value.

The valuation range spans from ₹13.40 to ₹33.96, indicating ₹13.40 - ₹33.96.

Is NOVELIX undervalued or overvalued?

Based on our multi-method analysis, Trimurthi (NOVELIX) appears to be trading above calculated value by approximately 70.0%.

NOVELIX Financial Health — Key Ratios vs Industry Benchmarks

Trimurthi financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Operating Margin -15.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.44x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

NOVELIX Cash Flow Quality — Operating & Free Cash Flow

Trimurthi operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2022 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10
March 2021 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10
March 2020 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10
March 2019 ₹-1 Cr ₹-1 Cr Negative Cash Flow 3/10
March 2018 ₹0 Cr ₹-1 Cr Negative Cash Flow 3/10